secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOLIFE SOLUTIONS INC (BLFS)
CIK:        0000834365
Form:       8-K
Filed at:   2026-06-03T12:03:31+00:00
Accession:  0001628280-26-040048
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioLife Solutions issues investor presentation for Jefferies conference; no material updates disclosed
--------------------------------------------------------------------------------

- Presentation dated June 3, 2026, furnished as Exhibit 99.1.
- Available on company website and used at Jefferies Global Healthcare Conference.
- No new financial guidance, business updates, or key metrics provided in the filing.
- Presentation cover cites 'Industry-Leading Solutions for Cell-Based Therapies'.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/834365/000162828026040048/0001628280-26-040048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/834365/000162828026040048/blfs-20260603.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-040048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer